Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 731,783 K
  • Annual Income, $ 43,642 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.6400 +2.13%
on 01/05/26
5.9500 -3.19%
on 01/05/26
-1.4700 (-20.33%)
since 12/05/25
3-Month
5.6400 +2.13%
on 01/05/26
14.2600 -59.61%
on 10/08/25
-8.0400 (-58.26%)
since 10/07/25
52-Week
5.2000 +10.77%
on 06/20/25
14.2600 -59.61%
on 10/08/25
-4.4320 (-43.49%)
since 12/09/24

Most Recent Stories

More News
Innocan Pharma Secures Patent for LPT-CBD in Japan, Strengthening Global IP Portfolio

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. InnoCan Pharma...

INNPF : 5.7600 (-2.70%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.1000 (-5.37%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

HERZLIYA, Israel and CALGARY, AB , Sept. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in...

INNO : 17.72 (+0.57%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

HERZLIYA, Israel and CALGARY, Alberta , Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.1000 (-5.37%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma Announces Details of Proposed Share Consolidation

/CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release...

INNO.CN : 8.1000 (-5.37%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma Announces Details of Proposed Share Consolidation

HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

INNO : 17.72 (+0.57%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma Announces First Half Of 2025 Financial Results

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 8.1000 (-5.37%)
INNPF : 5.7600 (-2.70%)
Innocan Pharma Announces First Half Of 2025 Financial Results

HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a...

INNO : 17.72 (+0.57%)
INNPF : 5.7600 (-2.70%)
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 8.1000 (-5.37%)
INNPF : 5.7600 (-2.70%)

Key Turning Points

3rd Resistance Point 5.7600
2nd Resistance Point 5.7600
1st Resistance Point 5.7600
Last Price 5.7600
1st Support Level 5.7600
2nd Support Level 5.7600
3rd Support Level 5.7600

See More

52-Week High 14.2600
Fibonacci 61.8% 10.7991
Fibonacci 50% 9.7300
Fibonacci 38.2% 8.6609
Last Price 5.7600
52-Week Low 5.2000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar